United States · FDA National Drug Code directory

METFORMIN HYDROCHLORIDE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 10135-824_552f9cd1-3596-e2aa-e063-6294a90a8219
Product NDC: 10135-824
Form: TABLET, EXTENDED RELEASE
Composition / generic term: METFORMIN HYDROCHLORIDE
Labeler: Marlex Pharmaceuticals, Inc.
Marketing category: ANDA
Marketing start / end (source format): 20260901
Source listing expiry: 20271231

Source-listed ingredients

METFORMIN HYDROCHLORIDE — 750 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

500 TABLET, EXTENDED RELEASE in 1 BOTTLE (10135-824-05) · 10135-824-05
1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (10135-824-10) · 10135-824-10
90 TABLET, EXTENDED RELEASE in 1 BOTTLE (10135-824-90) · 10135-824-90

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →